Canada Pension Plan Investment Board purchased a new position in shares of AngioDynamics, Inc. (NASD

Bank of America Corp DE grew its holdings in shares of AngioDynamics, Inc. (NASDAQ: ANGO) by 262.7%

AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock?

Gainers ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market

AngioDynamics NASDAQ: ANGO expects its MedTech business to become the majority of company revenue in

AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising c

AngioDynamics' fiscal 2027 outlook hinges on Med Tech growth offsetting flat device sales as tariffs

AngioDynamics' 33.5% three-month rally rests on Med Tech growth, but valuation, tariffs and negative

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medi

AngioDynamics develops tools for minimally invasive procedures across blood flow, blocked arteries,

HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and rais

ANGO's Q4 FY26 revenues rise 8% as Med Tech surges, while its adjusted loss beats estimates and FY27

Canaccord Genuity analyst John Young maintains AngioDynamics (NASDAQ:ANGO) with a Buy and raises

AngioDynamics, Inc. (ANGO) Q4 2026 Earnings Call Transcript

AngioDynamics NASDAQ: ANGO reported higher fiscal fourth-quarter and full-year revenue, driven by co

AngioDynamics (NASDAQ:ANGO) released fourth-quarter financial results and hosted an earnings call on

AngioDynamics (ANGO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Es

Companies Reporting Before The Bell • Grupo Aeroportuario del (NYSE:PAC) is likely to report quarter

AngioDynamics (NASDAQ:ANGO) is looking for FY2027 Adj EPS of $(0.29)-$(0.24) vs $(0.16) analyst esti

AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.07) per share which beat the analyst co

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medi

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focu

ANGO's NanoKnife growth, strong Med Tech momentum and solid Q3 results support holding the stock des

AngioDynamics' FDA IDE approval for RELIEF advances NanoKnife IRE study as a potential minimally inv

AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring healthy blood f

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focu

AngioDynamics, Inc. (ANGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 P

U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock

Pivotal U.S. Data Show Sustained Oncologic Control and Safety Profile at 24 monthsResults Presented

Canaccord Genuity analyst John Young maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers

AngioDynamics (NASDAQ:ANGO) raises FY2026 Adj EPS guidance from $(0.33)-$(0.23) to $(0.30)-$(0.23) v

AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.07) per share which beat the analyst co

Stocks end higher, Fear & Greed Index eases, Trump suggests quick military withdrawal from Iran,

U.S. stock futures trading lower, Acuity and Visionary Holdings report strong earnings, Lindsay Cor

Growing Clinical Evidence and Physician Adoption Broaden NanoKnife IRE Technology as Treatment Optio

U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures o